ESRRG and esophageal squamous cell carcinoma: These groundbreaking discoveries provide novel insights into the molecular mechanisms through which ESRRG exerts its inhibitory effects on ESCC development, opening up possibilities for developing targeted pharmacotherapies aimed at ESRRG and its downstream targets.